Oral Mycobiome and COVID-19
Data Availability Statement
Conflicts of Interest
References
- Di Spirito, F.; Pelella, S.; Argentino, S.; Sisalli, L.; Sbordone, L. Oral Manifestations and the Role of the Oral Healthcare Workers in COVID-19. Oral Dis. 2022, 28, 1003–1004. [Google Scholar] [CrossRef]
- Di Spirito, F.; Iandolo, A.; Amato, A.; Caggiano, M.; Raimondo, A.; Lembo, S.; Martina, S. Prevalence, Features and Degree of Association of Oral Lesions in COVID-19: A Systematic Review of Systematic Reviews. Int. J. Environ. Res. Public Health 2022, 19, 7486. [Google Scholar] [CrossRef] [PubMed]
- Di Spirito, F.; Amato, A.; Di Palo, M.P.; Ferraro, G.A.; Baroni, A.; Serpico, R.; Contaldo, M. COVID-19 Related Information on Pediatric Dental Care Including the Use of Teledentistry: A Narrative Review. Children 2022, 9, 1942. [Google Scholar] [CrossRef] [PubMed]
- Meawed, T.E.; Ahmed, S.M.; Mowafy, S.M.S.; Samir, G.M.; Anis, R.H. Bacterial and Fungal Ventilator Associated Pneumonia in Critically Ill COVID-19 Patients during the Second Wave. J. Infect. Public Health 2021, 14, 1375–1380. [Google Scholar] [CrossRef] [PubMed]
- Nambiar, M.; Varma, S.R.; Jaber, M.; Sreelatha, S.V.; Thomas, B.; Nair, A.S. Mycotic Infections–Mucormycosis and Oral Candidiasis Associated with COVID-19: A Significant and Challenging Association. J. Oral. Microbiol. 2021, 13, 1967699. [Google Scholar] [CrossRef] [PubMed]
- D’Ambrosio, F.; Caggiano, M.; Acerra, A.; Pisano, M.; Giordano, F. Is Ozone a Valid Adjuvant Therapy for Periodontitis and Peri-Implantitis? A Systematic Review. J. Pers. Med. 2023, 13, 646. [Google Scholar] [CrossRef]
- D’Ambrosio, F.; Di Spirito, F.; Amato, A.; Caggiano, M.; Lo Giudice, R.; Martina, S. Attitudes towards Antibiotic Prescription and Antimicrobial Resistance Awareness among Italian Dentists: What Are the Milestones? Healthcare 2022, 10, 1585. [Google Scholar] [CrossRef]
- D’Ambrosio, F.; Di Spirito, F.; De Caro, F.; Lanza, A.; Passarella, D.; Sbordone, L. Adherence to Antibiotic Prescription of Dental Patients: The Other Side of the Antimicrobial Resistance. Healthcare 2022, 10, 1636. [Google Scholar] [CrossRef]
- Erami, M.; Raiesi, O.; Momen-Heravi, M.; Getso, M.I.; Fakhrehi, M.; Mehri, N.; Yarahmadi, M.; Amiri, S.; Raissi, V.; Hashemi, S.J. Clinical Impact of Candida Respiratory Tract Colonization and Acute Lung Infections in Critically Ill Patients with COVID-19 Pneumonia. Microb. Pathog. 2022, 166, 105520. [Google Scholar] [CrossRef]
- Tsai, C.-S.; Lee, S.S.-J.; Chen, W.-C.; Tseng, C.-H.; Lee, N.-Y.; Chen, P.-L.; Li, M.-C.; Syue, L.-S.; Lo, C.-L.; Ko, W.-C.; et al. COVID-19-Associated Candidiasis and the Emerging Concern of Candida Auris Infections. J. Microbiol. Immunol. Infect. 2022, in press. [CrossRef]
- Wu, H.-Y.; Chang, P.-H.; Chen, K.-Y.; Lin, I.-F.; Hsih, W.-H.; Tsai, W.-L.; Chen, J.-A.; Lee, S.S.-J. Coronavirus Disease 2019 (COVID-19) Associated Bacterial Coinfection: Incidence, Diagnosis and Treatment. J. Microbiol. Immunol. Infect. 2022, 55, 985–992. [Google Scholar] [CrossRef] [PubMed]
- Yazdanpanah, S.; Ahmadi, M.; Zare, Z.; Nikoupour, H.; Arabsheybani, S.; Jabrodini, A.; Eghtedarnejad, E.; Chamanpara, P.; Geramizadeh, B.; Anbardar, M.H.; et al. Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-Infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates. Mycopathologia 2022, 1–12, Advance online publication. [Google Scholar] [CrossRef] [PubMed]
- Di Spirito, F.; Caggiano, M.; Di Palo, M.P.; Contaldo, M.; D’Ambrosio, F.; Martina, S.; Amato, A. Oral Lesions in Pediatric Subjects: SARS-CoV-2 Infection and COVID-19 Vaccination. Appl. Sci. 2022, 12, 8995. [Google Scholar] [CrossRef]
- Zhang, D.; Li, S.; Wang, N.; Tan, H.-Y.; Zhang, Z.; Feng, Y. The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases. Front. Microbiol. 2020, 11, 301. [Google Scholar] [CrossRef] [PubMed]
- Amato, M.; Di Spirito, F.; D’Ambrosio, F.; Boccia, G.; Moccia, G.; De Caro, F. Probiotics in Periodontal and Peri-Implant Health Management: Biofilm Control, Dysbiosis Reversal, and Host Modulation. Microorganisms 2022, 10, 2289. [Google Scholar] [CrossRef]
- Amato, A. Oral-Systemic Health and Disorders: Latest Advances on Oral–Gut–Lung Microbiome Axis. Appl. Sci. 2022, 12, 8213. [Google Scholar] [CrossRef]
- Di Spirito, F.; Sbordone, L.; Pilone, V.; D’Ambrosio, F. Obesity and Periodontal Disease: A Narrative Review on Current Evidence and Putative Molecular Links. Open Dent. J. 2020, 13, 526–536. [Google Scholar] [CrossRef]
- Khan, M.; Alasqah, M.; Alammar, L.; Alkhaibari, Y. Obesity and Periodontal Disease: A Review. J. Fam. Med. Prim. Care 2020, 9, 2650. [Google Scholar] [CrossRef]
- Bui, F.Q.; Almeida-da-Silva, C.L.C.; Huynh, B.; Trinh, A.; Liu, J.; Woodward, J.; Asadi, H.; Ojcius, D.M. Association between Periodontal Pathogens and Systemic Disease. Biomed. J. 2019, 42, 27–35. [Google Scholar] [CrossRef]
- Di Spirito, F. Oral-Systemic Health and Disorders: Latest Prospects on Oral Antisepsis. Appl. Sci. 2022, 12, 8185. [Google Scholar] [CrossRef]
- Zuo, T.; Wu, X.; Wen, W.; Lan, P. Gut Microbiome Alterations in COVID-19. Genom. Proteom. Bioinform. 2021, 19, 679–688. [Google Scholar] [CrossRef]
- Sonoyama, K.; Miki, A.; Sugita, R.; Goto, H.; Nakata, M.; Yamaguchi, N. Gut Colonization by Candida Albicans Aggravates Inflammation in the Gut and Extra-Gut Tissues in Mice. Med. Mycol. 2011, 49, 237–247. [Google Scholar] [CrossRef] [PubMed]
- Di Spirito, F.; Amato, A.; Di Palo, M.P.; Contaldo, M.; D’Ambrosio, F.; Lo Giudice, R.; Amato, M. Oral Lesions Following Anti-SARS-CoV-2 Vaccination: A Systematic Review. Int. J. Environ. Res. Public Health 2022, 19, 10228. [Google Scholar] [CrossRef] [PubMed]
- Di Spirito, F.; Argentino, S.; Martuscelli, R.; Sbordone, L. Mronj Incidence after Multiple Teeth Extractions in Patients Taking Oral Bis-Phosphonates without “Drug Holiday”: A retrospective chart review. Oral Ijmplantol. 2019, 12, 105–110. [Google Scholar]
- Barone, A.; Chatelain, S.; Derchi, G.; Di Spirito, F.; Martuscelli, R.; Porzio, M.; Sbordone, L. Antibiotic’s Effectiveness after Erupted Tooth Extractions: A Retrospective Study. Oral Dis. 2020, 26, 967–973. [Google Scholar] [CrossRef]
- Arendrup, M.C.; Patterson, T.F. Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment. J. Infect. Dis. 2017, 216, S445–S451. [Google Scholar] [CrossRef] [Green Version]
- Lone, S.A.; Ahmad, A. Candida Auris—The Growing Menace to Global Health. Mycoses 2019, 62, 620–637. [Google Scholar] [CrossRef] [Green Version]
- Di Spirito, F.; Iacono, V.J.; Alfredo, I.; Alessandra, A.; Sbordone, L.; Lanza, A. Evidence-Based Recommendations on Periodontal Practice and the Management of Periodontal Patients During and After the COVID-19 Era: Challenging Infectious Diseases Spread by Airborne Transmission. Open Dent. J. 2021, 15, 325–336. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
D’Ambrosio, F. Oral Mycobiome and COVID-19. Microorganisms 2023, 11, 982. https://doi.org/10.3390/microorganisms11040982
D’Ambrosio F. Oral Mycobiome and COVID-19. Microorganisms. 2023; 11(4):982. https://doi.org/10.3390/microorganisms11040982
Chicago/Turabian StyleD’Ambrosio, Francesco. 2023. "Oral Mycobiome and COVID-19" Microorganisms 11, no. 4: 982. https://doi.org/10.3390/microorganisms11040982